|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
247 a.a.
|
 |
|
|
|
|
|
|
|
156 a.a.
|
 |
|
|
|
|
|
|
|
262 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/peptide
|
 |
|
Title:
|
 |
Crystal structure of aminoglycoside phosphotransferase aph(3')-iiia in complex with the inhibitor ar_3a
|
|
Structure:
|
 |
Aminoglycoside 3'-phosphotransferase. Chain: a, c. Synonym: aph iiia, kanamycin kinase type iii, neomycin-kanamycin phosphotransferase type iii, aph(3')iii. Engineered: yes. Mutation: yes. Designed ankyrin repeat inhibitor ar_3a. Chain: b, d. Engineered: yes
|
|
Source:
|
 |
Enterococcus faecalis. Organism_taxid: 1351. Expressed in: escherichia coli. Expression_system_taxid: 469008. Other_details: streptococcus faecalis, staphylococcus aureus. Synthetic construct. Organism_taxid: 32630. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.15Å
|
R-factor:
|
0.200
|
R-free:
|
0.260
|
|
|
Authors:
|
 |
A.Kohl,P.Amstutz,P.Parizek,H.K.Binz,C.Briand,G.Capitani,P.Forrer, A.Pluckthun,M.G.Grutter
|
Key ref:
|
 |
A.Kohl
et al.
(2005).
Allosteric inhibition of aminoglycoside phosphotransferase by a designed ankyrin repeat protein.
Structure (Camb),
13,
1131-1141.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
16-Feb-05
|
Release date:
|
09-Aug-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P0A3Y5
(KKA3_ENTFL) -
Aminoglycoside 3'-phosphotransferase from Enterococcus faecalis
|
|
|
|
Seq: Struc:
|
 |
 |
 |
264 a.a.
247 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, C:
E.C.2.7.1.95
- kanamycin kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
kanamycin A + ATP = kanamycin 3'-phosphate + ADP + H+
|
 |
 |
 |
 |
 |
kanamycin A
|
+
|
ATP
|
=
|
kanamycin 3'-phosphate
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Structure (Camb)
13:1131-1141
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Allosteric inhibition of aminoglycoside phosphotransferase by a designed ankyrin repeat protein.
|
|
A.Kohl,
P.Amstutz,
P.Parizek,
H.K.Binz,
C.Briand,
G.Capitani,
P.Forrer,
A.Plückthun,
M.G.Grütter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Aminoglycoside phosphotransferase (3')-IIIa (APH) is a bacterial kinase that
confers antibiotic resistance to many pathogenic bacteria and shares structural
homology with eukaryotic protein kinases. We report here the crystal structure
of APH, trapped in an inactive conformation by a tailor-made inhibitory ankyrin
repeat (AR) protein, at 2.15 A resolution. The inhibitor was selected from a
combinatorial library of designed AR proteins. The AR protein binds the
C-terminal lobe of APH and thereby stabilizes three alpha helices, which are
necessary for substrate binding, in a significantly displaced conformation.
BIAcore analysis and kinetic enzyme inhibition experiments are consistent with
the proposed allosteric inhibition mechanism. In contrast to most small-molecule
kinase inhibitors, the AR proteins are not restricted to active site binding,
allowing for higher specificity. Inactive conformations of pharmaceutically
relevant enzymes, as can be elucidated with the approach presented here,
represent powerful starting points for rational drug design.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 2.
Figure 2. Crystal Structure of the mAPH in Complex with the
AR Protein AR_3a (A) Stereo view of the AB heterodimer of
the mAPH/AR_3a complex. The mAPH is shown in orange, and the
AR_3a is shown in light blue. AR_3a binds to the C-terminal lobe
of the mAPH and stabilizes an inactive conformation. (B)
Asymmetric mAPH pseudo-homodimer found in the crystal of the
mAPH/AR_3a complex. (C) Symmetric wtAPH dimer found in the
wtAPH crystal. (D) Stereo view of the superposition of the
mAPH hetereodimer AB (orange) and BC (light blue). (E)
wtAPH in the kanamycin A bound form (PDB: 1L8T1L8T). ADP and
kanamycin A are labeled. (F) mAPH/AR_3a AB heterodimer in
the same orientation as the wtAPH in (E).
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure (Camb)
(2005,
13,
1131-1141)
copyright 2005.
|
|
| |
Figure was
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.R.Bradbury,
S.Sidhu,
S.Dübel,
and
J.McCafferty
(2011).
Beyond natural antibodies: the power of in vitro display technologies.
|
| |
Nat Biotechnol,
29,
245-254.
|
 |
|
|
|
|
 |
J.Karanicolas,
J.E.Corn,
I.Chen,
L.A.Joachimiak,
O.Dym,
S.H.Peck,
S.Albeck,
T.Unger,
W.Hu,
G.Liu,
S.Delbecq,
G.T.Montelione,
C.P.Spiegel,
D.R.Liu,
and
D.Baker
(2011).
A de novo protein binding pair by computational design and directed evolution.
|
| |
Mol Cell,
42,
250-260.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Monroe,
G.Sennhauser,
M.A.Seeger,
C.Briand,
and
M.G.Grütter
(2011).
Designed ankyrin repeat protein binders for the crystallization of AcrB: Plasticity of the dominant interface.
|
| |
J Struct Biol,
174,
269-281.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.De Pascale,
and
G.D.Wright
(2010).
Antibiotic resistance by enzyme inactivation: from mechanisms to solutions.
|
| |
Chembiochem,
11,
1325-1334.
|
 |
|
|
|
|
 |
M.S.Ramirez,
and
M.E.Tolmasky
(2010).
Aminoglycoside modifying enzymes.
|
| |
Drug Resist Updat,
13,
151-171.
|
 |
|
|
|
|
 |
D.H.Fong,
and
A.M.Berghuis
(2009).
Structural basis of APH(3')-IIIa-mediated resistance to N1-substituted aminoglycoside antibiotics.
|
| |
Antimicrob Agents Chemother,
53,
3049-3055.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Veesler,
B.Dreier,
S.Blangy,
J.Lichière,
D.Tremblay,
S.Moineau,
S.Spinelli,
M.Tegoni,
A.Plückthun,
V.Campanacci,
and
C.Cambillau
(2009).
Crystal structure and function of a DARPin neutralizing inhibitor of lactococcal phage TP901-1: comparison of DARPin and camelid VHH binding mode.
|
| |
J Biol Chem,
284,
30718-30726.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Gebauer,
and
A.Skerra
(2009).
Engineered protein scaffolds as next-generation antibody therapeutics.
|
| |
Curr Opin Chem Biol,
13,
245-255.
|
 |
|
|
|
|
 |
P.Milovnik,
D.Ferrari,
C.A.Sarkar,
and
A.Plückthun
(2009).
Selection and characterization of DARPins specific for the neurotensin receptor 1.
|
| |
Protein Eng Des Sel,
22,
357-366.
|
 |
|
|
|
|
 |
S.Koide
(2009).
Engineering of recombinant crystallization chaperones.
|
| |
Curr Opin Struct Biol,
19,
449-457.
|
 |
|
|
|
|
 |
D.Frey,
T.Huber,
A.Plückthun,
and
M.G.Grütter
(2008).
Structure of the recombinant antibody Fab fragment f3p4.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
636-643.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.T.Stumpp,
H.K.Binz,
and
P.Amstutz
(2008).
DARPins: a new generation of protein therapeutics.
|
| |
Drug Discov Today,
13,
695-701.
|
 |
|
|
|
|
 |
T.M.Bandeiras,
R.C.Hillig,
P.M.Matias,
U.Eberspaecher,
J.Fanghänel,
M.Thomaz,
S.Miranda,
K.Crusius,
V.Pütter,
P.Amstutz,
M.Gulotti-Georgieva,
H.K.Binz,
C.Holz,
A.A.Schmitz,
C.Lang,
P.Donner,
U.Egner,
M.A.Carrondo,
and
B.Müller-Tiemann
(2008).
Structure of wild-type Plk-1 kinase domain in complex with a selective DARPin.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
339-353.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Schweizer,
H.Roschitzki-Voser,
P.Amstutz,
C.Briand,
M.Gulotti-Georgieva,
E.Prenosil,
H.K.Binz,
G.Capitani,
A.Baici,
A.Plückthun,
and
M.G.Grütter
(2007).
Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism.
|
| |
Structure,
15,
625-636.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.D.Wright,
and
A.D.Sutherland
(2007).
New strategies for combating multidrug-resistant bacteria.
|
| |
Trends Mol Med,
13,
260-267.
|
 |
|
|
|
|
 |
M.Kawe,
P.Forrer,
P.Amstutz,
and
A.Plückthun
(2006).
Isolation of intracellular proteinase inhibitors derived from designed ankyrin repeat proteins by genetic screening.
|
| |
J Biol Chem,
281,
40252-40263.
|
 |
|
|
|
|
 |
R.J.Hosse,
A.Rothe,
and
B.E.Power
(2006).
A new generation of protein display scaffolds for molecular recognition.
|
| |
Protein Sci,
15,
14-27.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2006).
Survey of the year 2005 commercial optical biosensor literature.
|
| |
J Mol Recognit,
19,
478-534.
|
 |
|
|
|
|
 |
H.K.Binz,
and
A.Plückthun
(2005).
Engineered proteins as specific binding reagents.
|
| |
Curr Opin Biotechnol,
16,
459-469.
|
 |
|
|
|
|
 |
H.K.Binz,
P.Amstutz,
and
A.Plückthun
(2005).
Engineering novel binding proteins from nonimmunoglobulin domains.
|
| |
Nat Biotechnol,
23,
1257-1268.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|